Clinical Trial Update: Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's [Phase 3]

View source ↗

Summary

Phase 3 global efficacy study of MPC-7869 for Alzheimer's disease and dementia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• MPC-7869

Snippet

Sponsor: Myrexis Inc. | Conditions: Alzheimer Disease, Dementia | Phase 3 | Status: TERMINATED